NMAVX
Price
$13.57
Change
-$0.14 (-1.02%)
Updated
Sep 20 closing price
VMVAX
Price
$86.17
Change
-$0.37 (-0.43%)
Updated
Sep 20 closing price
Ad is loading...

NMAVX vs VMVAX

Header iconNMAVX vs VMVAX Comparison
Open Charts NMAVX vs VMVAXBanner chart's image
Nuance Mid Cap Value Investor
Price$13.57
Change-$0.14 (-1.02%)
VolumeN/A
CapitalizationN/A
Vanguard Mid-Cap Value Index Admiral
Price$86.17
Change-$0.37 (-0.43%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
NMAVX vs VMVAX Comparison Chart
Loading...
VS
NMAVX vs. VMVAX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NMAVX is a StrongBuy and VMVAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 30.5B vs. NMAVX (1.66B). VMVAX pays higher dividends than NMAVX: VMVAX (2.14) vs NMAVX (1.47). NMAVX was incepted earlier than VMVAX: NMAVX (11 years) vs VMVAX (13 years). NMAVX is a more actively managed with annual turnover of: 62.00 vs. VMVAX (22.00). NMAVX has a lower initial minimum investment than VMVAX: NMAVX (2500) vs VMVAX (3000). VMVAX annual gain was more profitable for investors over the last year : 25.35 vs. NMAVX (20.35). VMVAX return over 5 years is better than : 48.82 vs. NMAVX (6.65).
NMAVXVMVAXNMAVX / VMVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years13 years-
Gain YTD9.17914.94661%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets1.66B30.5B5%
Annual Yield % from dividends1.472.1469%
Returns for 1 year20.3525.3580%
Returns for 3 years-7.1320.71-34%
Returns for 5 years6.6548.8214%
Returns for 10 years38.02100.8838%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AUUD0.790.01
+0.67%
Auddia
CTLT60.00-0.11
-0.18%
CATALENT
JAMF18.49-0.09
-0.48%
Jamf Holding Corp
ARCT20.61-0.41
-1.95%
Arcturus Therapeutics Holdings
ANVS8.47-0.17
-1.97%
Annovis Bio